Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/HROW/vs peers

HROWHARROW, INC.vs its industry peers

A metric-by-metric comparison of HARROW, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
HROWHARROW, INC.Esta$1.0B#8—69.0x#123.9x#436.4%#370.6%#211.2%#3-33.8%#813.2%#46#1-25.9%#8—
RAPPRapport Therapeutics, Inc.$1.2B#1—2.8x#8——-42.4%#8—-26.4%#6——-14.4%#7—
SNDXSyndax Pharmaceuticals Inc$1.2B#2——6.8x#5627.8%#110.5%#3-158.4%#5—-143.0%#7—-4.0%#6—
AMPHAmphastar Pharmaceuticals, Inc.$1.1B#315.9x#22.6x#61.6x#1-1.7%#6-38.5%#719.5%#222.0%#213.2%#35#25.4%#5—
AVLNAvalyn Pharma Inc.$1.1B#4—2.8x#9————0.0%#3————
MNKDMANNKIND CORP$1.1B#5——3.2x#322.2%#5-78.7%#1111.1%#4—2283.8%#1—-37.6%#10—
JANXJanux Therapeutics, Inc.$1.1B#6—1.2x#1107.8x#7-5.6%#7-64.7%#10-1576.7%#7-12.2%#5——-38.6%#11—
SPTXSeaport Therapeutics, Inc.$1.1B#7—2.6x#7————0.0%#3————
SVRASavara Inc$971M#9—6.8x#103777.4x#8—-23.9%#6-48072.8%#8-82.7%#11-93.6%#6—13.6%#3—
MLTXMoonLake Immunotherapeutics$969M#10—2.3x#4——-91.1%#13—-53.1%#10-491.6%#8—13.0%#4—
ORICOric Pharmaceuticals, Inc.$958M#11—2.5x#5——-1.3%#4—-34.0%#9-40.4%#5—-29.8%#9—
RIGLRIGEL PHARMACEUTICALS INC$944M#123.0x#12.2x#33.2x#264.1%#21999.1%#142.6%#186.3%#130.6%#2—60.0%#1—
LTGO$908M#13———————————
KURA$890M#14—18.4x#1113.2x#625.2%#4-60.2%#9-449.9%#6-575.4%#12————
OBXGazelle Parent, Inc.$890M#15————-21.1%#5——————
JBIOJade Biosciences, Inc.$866M#16—2.0x#2——-83.0%#12—-29.0%#7——39.1%#2—

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

HROW's peers

RAPPSNDXAMPHAVLNMNKDJANXSPTXSVRAMLTXORICRIGLLTGOKURAOBXJBIO
← HROW overview